Haleon plc (ADR)
General ticker "HLN" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $45.4B (TTM average)
Haleon plc (ADR) does not follow the US Stock Market performance with the rate: -18.7%.
Estimated limits based on current volatility of 0.9%: low 9.73$, high 9.90$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-08-15, amount 0.06$ (Y1.22%)
- Total employees count: 24622 as of 2022
Short-term HLN quotes
Long-term HLN plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | £10,858.00MM | £11,302.00MM | £11,233.00MM |
| Operating Expenses | £9,033.00MM | £9,306.00MM | £9,027.00MM |
| Operating Income | £1,825.00MM | £1,996.00MM | £2,206.00MM |
| Non-Operating Income | £-207.00MM | £-368.00MM | £-296.00MM |
| Interest Expense | £347.36MM | £414.00MM | £394.00MM |
| R&D Expense | £300.00MM | £311.00MM | £298.00MM |
| Income(Loss) | £1,618.00MM | £1,628.00MM | £1,910.00MM |
| Taxes | £499.00MM | £517.00MM | £435.00MM |
| Profit(Loss)* | £1,060.00MM | £1,049.00MM | £1,442.00MM |
| Stockholders Equity | £16,331.00MM | £16,606.00MM | £16,166.00MM |
| Inventory | £1,348.00MM | £1,408.00MM | £1,190.00MM |
| Assets | £34,815.00MM | £34,055.00MM | £34,315.00MM |
| Operating Cash Flow | £2,063.00MM | £2,100.00MM | £2,301.00MM |
| Capital expenditure | £328.00MM | £336.00MM | £250.00MM |
| Investing Cash Flow | £-8,784.00MM | £-134.00MM | £528.00MM |
| Financing Cash Flow | £6,911.00MM | £-1,568.00MM | £-1,537.00MM |
| Earnings Per Share** | £0.23 | £0.23 | £0.32 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.